儿科肾脏病学中的生物标志物——从床边到实验室再回到床边
Biomarkers in Pediatric Nephrology-From Bedside to Bench and Back Again.
作者信息
Musiał Kinga
机构信息
Department of Pediatric Nephrology, Wrocław Medical University, Borowska 213, 50-556 Wrocław, Poland.
出版信息
J Clin Med. 2022 Oct 7;11(19):5919. doi: 10.3390/jcm11195919.
Abstract
The progress in biomarker research is characterized by the perpetual quest for parameters that fulfill the strict criteria of sensitivity, specificity, ease and speed in performance and cost-effectiveness [...].
摘要
生物标志物研究的进展特点是不断寻求符合敏感性、特异性、操作简便性和速度以及成本效益等严格标准的参数[……]。
相似文献
1
Biomarkers in Pediatric Nephrology-From Bedside to Bench and Back Again.
J Clin Med. 2022 Oct 7;11(19):5919. doi: 10.3390/jcm11195919.
2
From bedside to bench and back: Translating ASD models.
Prog Brain Res. 2018;241:113-158. doi: 10.1016/bs.pbr.2018.10.003. Epub 2018 Nov 7.
3
Tissue engineering: from the bedside to the bench and back to the bedside.
Pediatr Surg Int. 2020 Oct;36(10):1123-1133. doi: 10.1007/s00383-020-04722-z. Epub 2020 Jul 30.
4
YKL-40 in dialysis patients: another candidate in the quest for useful biomarkers in nephrology.
Kidney Int. 2018 Jan;93(1):21-22. doi: 10.1016/j.kint.2017.08.009.
5
Perspectives: From Bedside to Bench.
Am J Physiol Renal Physiol. 2015 Jul 1;309(1):F1. doi: 10.1152/ajprenal.00180.2015. Epub 2015 Apr 29.
6
Integration of Single-Center Data-Driven Vital Sign Parameters into a Modified Pediatric Early Warning System.
Pediatr Crit Care Med. 2017 May;18(5):469-476. doi: 10.1097/PCC.0000000000001150.
7
The long journey of cancer biomarkers from the bench to the clinic.
Clin Chem. 2013 Jan;59(1):147-57. doi: 10.1373/clinchem.2012.184614. Epub 2012 Sep 27.
8
Biomarkers: from bedside to bench and back again.
Am J Geriatr Psychiatry. 2002 Nov-Dec;10(6):644-5.
9
本文引用的文献
1
Applications of cardiac biomarkers in chronic kidney disease.
Curr Opin Nephrol Hypertens. 2022 Nov 1;31(6):534-540. doi: 10.1097/MNH.0000000000000829. Epub 2022 Aug 4.
2
Plasma biomarkers associated with survival and thrombosis in hospitalized COVID-19 patients.
Int J Hematol. 2022 Dec;116(6):937-946. doi: 10.1007/s12185-022-03437-2. Epub 2022 Aug 22.
3
Understanding COVID-19-associated coagulopathy.
Nat Rev Immunol. 2022 Oct;22(10):639-649. doi: 10.1038/s41577-022-00762-9. Epub 2022 Aug 5.
4
Biomarkers in Nephropathic Cystinosis: Current and Future Perspectives.
Cells. 2022 Jun 4;11(11):1839. doi: 10.3390/cells11111839.
5
Proteomics and Extracellular Vesicles as Novel Biomarker Sources in Peritoneal Dialysis in Children.
Int J Mol Sci. 2022 May 18;23(10):5655. doi: 10.3390/ijms23105655.
6
Neonatal Acute Kidney Injury.
Front Pediatr. 2022 Apr 7;10:842544. doi: 10.3389/fped.2022.842544. eCollection 2022.
7
Artificial intelligence in glomerular diseases.
Pediatr Nephrol. 2022 Nov;37(11):2533-2545. doi: 10.1007/s00467-021-05419-8. Epub 2022 Mar 10.
8
Comparing accuracy of urinary biomarkers in differentiation of ureteropelvic junction obstruction from nonobstructive dilatation in children.
Pediatr Nephrol. 2022 Oct;37(10):2277-2287. doi: 10.1007/s00467-022-05488-3. Epub 2022 Mar 3.
9
Advances in proteomic profiling of pediatric kidney diseases.
Pediatr Nephrol. 2022 Oct;37(10):2255-2265. doi: 10.1007/s00467-022-05497-2. Epub 2022 Feb 26.
10
Diagnostic and Prognostic Biomarkers of Coronavirus Disease 2019 in Children.
J Trop Pediatr. 2022 Feb 3;68(2). doi: 10.1093/tropej/fmac003.
Zotero 插件